BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11248078)

  • 1. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
    Rothermel BA; McKinsey TA; Vega RB; Nicol RL; Mammen P; Yang J; Antos CL; Shelton JM; Bassel-Duby R; Olson EN; Williams RS
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3328-33. PubMed ID: 11248078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.
    Vega RB; Rothermel BA; Weinheimer CJ; Kovacs A; Naseem RH; Bassel-Duby R; Williams RS; Olson EN
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):669-74. PubMed ID: 12515860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
    Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
    J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of modulatory calcineurin-interacting proteins in calcineurin signaling.
    Rothermel BA; Vega RB; Williams RS
    Trends Cardiovasc Med; 2003 Jan; 13(1):15-21. PubMed ID: 12554096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function.
    Hill JA; Rothermel B; Yoo KD; Cabuay B; Demetroulis E; Weiss RM; Kutschke W; Bassel-Duby R; Williams RS
    J Biol Chem; 2002 Mar; 277(12):10251-5. PubMed ID: 11786544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
    Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.
    Yang J; Rothermel B; Vega RB; Frey N; McKinsey TA; Olson EN; Bassel-Duby R; Williams RS
    Circ Res; 2000 Dec; 87(12):E61-8. PubMed ID: 11110780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
    Pedram A; Razandi M; Lubahn D; Liu J; Vannan M; Levin ER
    Endocrinology; 2008 Jul; 149(7):3361-9. PubMed ID: 18372323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
    Sussman MA; Lim HW; Gude N; Taigen T; Olson EN; Robbins J; Colbert MC; Gualberto A; Wieczorek DF; Molkentin JD
    Science; 1998 Sep; 281(5383):1690-3. PubMed ID: 9733519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
    Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
    Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
    J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.
    Colbert MC; Hall DG; Kimball TR; Witt SA; Lorenz JN; Kirby ML; Hewett TE; Klevitsky R; Robbins J
    J Clin Invest; 1997 Oct; 100(8):1958-68. PubMed ID: 9329959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity.
    Vega RB; Yang J; Rothermel BA; Bassel-Duby R; Williams RS
    J Biol Chem; 2002 Aug; 277(33):30401-7. PubMed ID: 12063245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress.
    Frey N; Barrientos T; Shelton JM; Frank D; Rütten H; Gehring D; Kuhn C; Lutz M; Rothermel B; Bassel-Duby R; Richardson JA; Katus HA; Hill JA; Olson EN
    Nat Med; 2004 Dec; 10(12):1336-43. PubMed ID: 15543153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway.
    Bush E; Fielitz J; Melvin L; Martinez-Arnold M; McKinsey TA; Plichta R; Olson EN
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2870-5. PubMed ID: 14976250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.
    Rothermel B; Vega RB; Yang J; Wu H; Bassel-Duby R; Williams RS
    J Biol Chem; 2000 Mar; 275(12):8719-25. PubMed ID: 10722714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
    Zhang W
    Cardiovasc Res; 2002 Feb; 53(2):294-303. PubMed ID: 11827679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.